Navigation Links
NASA MidSTAR-1 successful technologies may be revolutionary
Date:2/19/2008

Two new technologies launched onboard a U.S. Naval Academy satellite called MidSTAR-1 have proven successful in their tests in space. One technology is a sensor that can check for harmful chemicals and the other is a special "film" that can control heat.

These technologies were collaboratively developed between NASAs Goddard Space Flight Center, Greenbelt, Md.; NASAs Ames Research Center, Moffett Field, Calif.; and Eclipse Energy Systems Inc. of various U.S. locations, respectively.

The nano chemsensor unit (NCSU), can sense chemicals and contaminants that may be harmful to astronauts, as well as a wide range of scientifically interesting compounds. "The chemical nanosensor is like a smoke detector that would fit on the end of an eraser," said Dan Powell, lead nanotechnologist for Goddard. The NCSU was developed by Dr. Jing Li of Ames. Goddard was instrumental in identifying applications, as well as facilitating this first-ever demonstration of applied nanotechnology in space, on-board MidStar-1.

The NCSU's successful operation aboard MidSTAR-1 proved that it senses target chemicals both accurately and repeatedly in space.

The NCSU uses a network of tiny carbon nanotubes that are about 10,000 times thinner than a human hair, to sense various gases and their concentrations. These nanosensors are developed for NASA missions, such as cabin air monitoring for a crew exploration vehicle, in-flight fuel leak detection, planetary exploration, and earth science observation. This experiment proved that the nanosensors is robust that can undergo the vigorous launch process and can work in the space environment, such as microgravity, radiation, temperature variation, and vacuum.

The sensor in orbit was designed to detect trace amounts of nitrogen dioxide, a common air pollutant. This capability, when combined with the unit's extremely small size, power consumption and heat output makes the NCSU useful to many industries. It
'/>"/>

Contact: Rob Gutro
Robert.J.Gutro@nasa.gov
301-286-4044
NASA/Goddard Space Flight Center
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
2. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
3. Phase I Safety and Tolerability Study With EVT 302 Successfully Completed
4. Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc
5. Laser Therapy Gives Smokers Hope for Successful New Years Resolution
6. Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results
7. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
8. James Webb Space Telescope marks successful completion
9. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
10. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
11. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NASA MidSTAR-1 successful technologies may be revolutionary
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... 2, 2015 Aytu BioScience, Inc. (OTCQB: AYTU), ... urological and related conditions, announced today that it has ... convertible note financing, raising a total of $5.175 million, ... million. Josh Disbrow , Chief ... placement are intended to be used to conduct clinical ...
(Date:9/2/2015)... , September 2, 2015 ... BOLT) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, announced today that presentations ... glaucoma will be delivered at the Ophthalmology Futures ... European Society of Cataract & Refractive Surgeons ("ESCRS"), ...
(Date:9/2/2015)... 2015 Biovista Inc. freut ... von 2015 bekanntgeben zu können. Hierbei handelt es ... Biovista unterstützt mit seiner Möglichkeit der ... anderer Krankheiten als denen, für die ein Medikament ... sein Team bei der Wylder Nation Foundation bei ...
Breaking Biology Technology:Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2
... by Rice University has brought a wealth of new information ... The current issue of the American Chemical Society journal ... the Rice lab of chemist Bruce Weisman to understand how ... in this case, the light they emit at near-infrared ...
... Realty Trust, Inc. (NYSE: BMR ) today announced ... ended December 31, 2011 after the market closes on Wednesday, ... and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive ... host an investor conference call at 10:00 a.m. Pacific Time ...
... DURHAM, N.C., Jan. 31, 2012  Argos Therapeutics Inc., ... immune monitoring analysis of AGS-003-006, a Phase 2 ... with sunitinib in patients with advanced renal cell ... correlation between anti-tumor memory T cell responses and ...
Cached Biology Technology:Perfect nanotubes shine brightest 2BioMed Realty Trust to Report 2011 Fourth Quarter and Year End Results 2Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC) 2Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC) 3
(Date:8/18/2015)... PRINCETON, N.J. , Aug. 18, 2015 ... be a key contributor to the Submission ... hosted by IRISS, a non-profit forum. Dedicated to ... IRISS provides a neutral platform for industry, ... to share information and work towards a ...
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/6/2015)... , Aug. 6, 2015  Today, U.S. Congressman ... Crossmatch ™ to learn firsthand how Silicon ... data. Crossmatch is a world leader in multi-factor ... expertise are helping federal agencies and commercial organizations ...   "The vast majority of network ...
Breaking Biology News(10 mins):Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3Rep. Honda to Visit Crossmatch in Redwood City 2
... disease. It occurs when changes take place in the ... cell signalling and blood vessel formation either due ... or radiation or due to inherited changes. This ... cancer is an extremely complex disease. Cancer of the ...
... University have found a molecular mechanism for anaphylactic ... cell walls of small blood vessels plays an ... from the potentially fatal reactions of the immune ... regulation. This paves the way for the development ...
... and Ann Arbor, MI, USA, Jan 28 , 2009 ... the Illumina-Connect program, linking them to the ongoing Illumina ... and applications for Illumina-generated data. , Klaus May, ... commented: "As the industry,s only provider of a complete ...
Cached Biology News:New research findings may enable earlier diagnosis of uterine cancer 2Molecular mechanism of anaphylactic shock decoded 2Genomatix joins Illumina-Connect program 2
... White solid. PROTECT FROM LIGHT. ... sulfanamido-benzbromarone compound that acts as a ... of PTP1B (IC 50 = ... PTP1B 403 and PTP1B 298 ...
Anti-NCAPD3 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunoprecipitation, Western Blot...
... BIP-NC H-IPMIK-OH Lyophilized solid. ... LIGHT. HYGROSCOPIC. PACKAGED UNDER INERT GAS. A ... V5 (Cat. No. 196810) that serves as ... apoptosis (~200 μM). Purity: ≥97% by ...
BD Falcon microtest assay plate. 1536 well 12l, black, flat-bottom PS. Polystyrene, nonsterile, no lid. (15/sp, 60/ca) Packaging: 15 / pack, 60 / case ...
Biology Products: